Multiple Sclerosis Clinical Trials in Los Angeles

Showing 381-400 of 489 trials

Small Bowel Capsule Endoscopy Findings in Patients Receiving Cellcept®

NCT00652834

The purpose of this study is to learn more about symptoms and gastrointestinal lesions associated with taking myfortic® by switching patients to a delayed release formulation that is developed to alleviate GI symptoms. A comparison of the frequency and severity of GI symptoms observed in patients treated with MMF (cellcept®) after conversion to myfortic® will be measured by using a self-assessed questionnaire called Gastrointestinal Symptom Rating Scale (GSRS). To prove the incidence and improvement of GI lesions in patients treated with MMF (cellcept®) after conversion to myfortic® will be measured by using Small Bowel Capsule Endoscopy (SBCE).

Gastrointestinal LesionsSigns and Symptoms, Digestive

University of California, Los Angeles23 participantsStarted Apr 2009

Los Angeles, California, United States

COMPLETEDPhase 2< 1 mile

Study For Patients With Untreated Gastric Cancer Who Will Receive Capecitabine And Lapatinib

NCT00526669

The study will determine if changes in expression of markers involved in the 5-FU pathways are associated with response to treatment with the combination of lapatinib and capecitabine independent of tumor erbB2 status.

Neoplasms, Gastrointestinal Tract

GlaxoSmithKline68 participantsStarted Mar 2008

Loma Linda, California, United States • Los Angeles, California, United States • Washington D.C., District of Columbia, United States +19 more locations

Small Bowel Capsule Endoscopy Findings in Patients Receiving Cellcept®

Study For Patients With Untreated Gastric Cancer Who Will Receive Capecitabine And Lapatinib

Multiple Sclerosis Trials in Other Cities

Study of Adding AMG 479 to First Line Chemotherapy in Patients With Optimally Debulked Epithelial Ovarian Cancer

Study of AMG 479 as Second Line Therapy in Patients With Recurrent Platinum-sensitive Ovarian Cancer

Study of Proxinium for Treating Patients With Squamous Cell Head and Neck Cancer

Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer

Lux-Breast 3; Afatinib Alone or in Combination With Vinorelbine in Patients With Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer Suffering From Brain Metastases

Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors

Exact CRC Screening Test: Stool Sample Collection Study to Support Assay Validation Testing

Safety Study for the Treatment of Abdominal Aortic Aneurysms

Safety and Tolerability of Glatiramer Acetate

Comparison of Safety and Efficacy of Tizanidine Hydrochloride Capsules Versus Zanaflex® (Tizanidine Hydrochloride Tablets) Taken While in the Fed State (Just After a Meal) and in the Fasted State (Before a Meal) in Patients With Moderate to Severe Spasticity.

A Safety and Efficacy Study of ELND002 in Patients With Relapsing Forms of Multiple Sclerosis

Safety and Efficacy Study of AR08 for the Treatment of Vasomotor Symptoms (VMS)

Phase III Study of Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer

Randomized Phase III Study Of Exemestane (Aromasin) For 5 Years Versus Tamoxifen for 2.5 to 3 Years Followed By Exemestane

Open Label Extension of Prior TERMS Study to Treat Relapsing Forms of Multiple Sclerosis

Randomized Controlled Trial of Tailored Interactive Multimedia to Reduce Colorectal Cancer Screening Disparities

Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies

Understanding Sleep Problems in Children With Autism Spectrum Disorder

Other Conditions in Los Angeles